A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis

7.3K views

DOI:

10.3791/57743

June 9th, 2018

In This Article

Summary

Here, we present a protocol to confirm the presence of point mutation for the diagnosis of hereditary transthyretin amyloidosis, using Ala97Ser, the most common endemic mutation in Taiwan, as an example.

Abstract

Genetic testing is the most reliable test for hereditary transthyretin related amyloidosis and should be performed in most cases of transthyretin amyloidosis (ATTR). ATTR is a rare but fatal disease with heterogeneous phenotypes; therefore, the diagnosis is sometimes delayed. With increasing attention and broader recognition on early manifestations of ATTR as well as emerging treatments, appropriate diagnostic studies, including the transthyretin (TTR) genetic test, to confirm the types and variants of ATTR are therefore fundamental to improve the prognosis. Genetic analyses with polymerase chain reaction (PCR) methods confirm the presence of TTR point mutations much more quickly and safer than conventional methods such as southern blot. Herein, we demonstrate genetic confirmation of the ATTR Ala97Ser mutation, the most common endemic mutation in Taiwan. The protocol comprises four main steps: collecting whole blood specimen, DNA extraction, genetic analysis of all four TTR exons with PCR, and DNA sequencing.

Introduction

Transthyretin (TTR) amyloidosis (ATTR) is the most common form of hereditary systemic amyloidosis1, and can be caused by an autosomal dominantly inherited mutation in the transthyretin (TTR) gene2. TTR mutations destabilize the tetrameric protein structure and lead to its dissociation into monomers that reassembles into amyloid fibrils2. More than 100 amyloidogenic TTR mutations have been reported worldwide1. Genetic analyses with polymerase chain reaction (PCR) methods confirm the presence of TTR point mutation and have advantages including avoiding the handling of radioac....

Access restricted. Please log in or start a trial to view this content.

Protocol

The testing performed in the laboratory was carried out in accordance with the requirements of the Clinical Laboratory Improvement Amendments (CLIA) of 1988, the regulations approved by the Institutional Review Board of Chang Gung Memorial Hospital and University (License no. 100-4470A3 and 104-2462A3). Informed consent was obtained from all patients.

1. Blood Specimen Collection

  1. Collect whole blood into commercially available EDTA-treated tubes. Mix gently and store blood sample at 4 °C until processing.

2. DNA Extraction from Peripheral Blood

Use a DNA Extractio....

Access restricted. Please log in or start a trial to view this content.

Results

Agarose gel electrophoresis of two patients and one healthy individual revealed bands of the expected sizes, including a 454 bp PCR product for exon 4 of the TTR gene (Figure 1).

Access restricted. Please log in or start a trial to view this content.

Discussion

There are two critical steps within the protocol. First, in order to have sufficient number of white blood cells, a hemodiluted specimen should be avoided11. Second, the use of appropriate PCR primers is fundamental to obtain reliable results12. We used the Primer-BLAST web tool to design the primers4,13; a minimum of 40 base pairs on each side of the four TTR exons should be covered. We also run BLAST on NCBI to ch.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We wish to thank Miss Shin-Fun Wu for her help in the experiments. This study was supported by a grant from the Chang Gung Medical Research Program (CMRPG3C0371, CMRPG3C0372, CMRPG3C0373) and IRB 100-4470A3, 104-2462A3, Taiwan.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
EDTA-treated tubesBD
DNA Extraction KitStratagen200600
NanoDrop ND2000 spectrophotometer Thermo Fisher ScientificNanoDrop 2000
Delicate Task WipersKimberly-ClarkKimtech Science Kimwipes
AmpliTaq Gold 360 DNA Polymerase kitApplied Biosystems4398823
TTR gene intronic primers Exon1F: 5’-TCAGATTGGCAGGGATAAGC-3’
Exon1R: 5’-GCAAAGCTGGAAGGAGTCAC-3’
Exon2F: 5’-TCTTGTTTCGCTCCAGATTTC-3’
Exon2R: 5’-TCTACCAAGTGAGGGGCAAA-3’
Exon3F: 5’-GTGTTAGTTGGTGGGGGTGT-3’
Exon3R: 5’-TGAGTAAAACTGTGCATTTCCTG-3’
Exon4F: 5’-GACTTCCGGTGGTCAGTCAT-3’
Exon4R: 5’-GCGTTCTGCCCAGATACTTT-3’
thermocyclerApplied BiosystemsGeneAmp PCR System 9700
electrophoresis cell ADVANCEMupid-2plus
DNA ladderProtechPT-M1-100
dyeBioLabsB7021
AlphaImager ECAlpha InnotechAlphaImager EC
automatic sequencer Applied Biosystems3730xl DNA Analyzer

References

  1. Planté-Bordeneuve, V., Said, G. Familial amyloid polyneuropathy. The Lancet Neurology. 10 (12), 1086-1097 (2011).
  2. Planté-Bordeneuve, V., et al. Long-term treatment of transthyretin familial amyloid polyneuropathy with tafamidis: a clinical and neurophysiological study. Journal of Neurology. 264

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Transthyretin AmyloidosisPCR MethodsDNA ExtractionAgarose Gel ElectrophoresisDNA SequencingTTR Gene MutationAla97Ser MutationHereditary ATTRBlood Specimen